NCT06952855

Observationa Study is a Prospective and Multi-institutional Observational Study.

Observational Study to Evaluate Effectiveness, Safety and Satisfaction Level of Zastaprazan (JAQBO®) Under Daily Treatment for Patients With Erosive Gastroesophageal Reflux Disease

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 5,536 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This observational study is a prospective, multi-institutional non intervention study to examine the prescription patterns, corresponding treatment effects and safety in routine clinical practice for patients prescribed for the treatment of gastroesophageal reflux disease.

Detailed description

The present observational study is designed to check effect and safety for patients who have been prescribed JAQBO for the treatment of erosive gastroesophageal reflux disease.

Conditions

• Erosive Reflux Disease
• Heartburn
• Acid Regurgitation

Timeline

• Start date: 2024-11-01
• Primary completion: 2025-04-23
• Completion: 2025-04-23
• First posted: 2025-05-01
• Last updated: 2025-05-13

Locations

1 site across 1 country: South Korea